▁St 6.5703125
. 1.6875
▁J 4.890625
ude 0.052093505859375
▁Medical 2.0859375
▁Inc 2.44921875
' 6.953125
s 0.0009579658508300781
▁third 6.74609375
- 0.5546875
qu 0.00716400146484375
arter 0.0003361701965332031
▁prof 4.32421875
its 0.0035610198974609375
▁were 2.84375
▁held 6.55078125
▁back 0.3369140625
▁due 5.0234375
▁to 0.0210113525390625
▁a 1.6767578125
▁missed 8.8984375
▁heart 7.2421875
▁val 2.005859375
ve 0.0013818740844726562
▁sale 2.666015625
▁to 3.42578125
▁Iran 8.6640625
▁and 2.0703125
▁other 3.15625
▁factors 2.001953125
, 0.6455078125
▁the 1.251953125
▁company 0.423828125
▁reported 3.181640625
▁on 0.83154296875
▁T 1.126953125
ues 4.220008850097656e-05
day 0.0003674030303955078
. 0.354736328125
<0x0A> 0.1922607421875
Acc 6.60546875
ording 0.0223541259765625
▁to 0.0093841552734375
▁the 1.345703125
▁report 2.2109375
, 0.1702880859375
▁the 1.013671875
▁medical 2.326171875
▁technology 3.04296875
▁company 0.326416015625
' 1.21484375
s 0.0009551048278808594
▁re 2.837890625
venue 0.0029754638671875
▁for 1.8837890625
▁the 0.044342041015625
▁third 1.15234375
▁quarter 0.052154541015625
▁grew 4.24609375
▁only 4.69140625
▁ 0.2445068359375
3 2.09375
% 1.6728515625
▁to 0.41015625
▁$ 0.1361083984375
1 0.5
. 0.032073974609375
5 2.740234375
4 2.478515625
▁billion 0.08990478515625
, 0.8779296875
▁falling 3.33203125
▁short 0.25146484375
▁of 0.0115203857421875
▁anal 0.98486328125
yst 0.0001704692840576172
s 0.2269287109375
' 0.045654296875
▁expect 0.9638671875
ations 0.0004303455352783203
▁of 0.77734375
▁$ 0.07513427734375
1 0.004299163818359375
. 0.00209808349609375
5 0.1644287109375
7 1.462890625
▁billion 0.0304718017578125
. 0.1671142578125
▁The 2.716796875
▁company 0.46240234375
' 0.857421875
s 0.0003046989440917969
▁net 1.1611328125
▁ear 2.02734375
nings 0.00528717041015625
▁for 2.021484375
▁the 0.01537322998046875
▁quarter 0.5576171875
▁were 1.51171875
▁reported 5.21875
▁to 1.568359375
▁be 0.25830078125
▁$ 0.14306640625
1 0.955078125
8 2.275390625
6 2.3203125
▁million 0.794921875
, 0.29833984375
▁down 2.294921875
▁from 0.58935546875
▁$ 0.221435546875
1 1.27734375
9 0.1859130859375
8 2.361328125
▁million 0.1015625
▁in 0.8095703125
▁the 0.08319091796875
▁same 0.71923828125
▁period 0.77685546875
▁last 0.4462890625
▁year 0.003612518310546875
. 0.14208984375
<0x0A> 0.1817626953125
St 1.7724609375
. 0.05255126953125
▁J 0.005733489990234375
ude 0.0009517669677734375
▁Medical 1.4580078125
▁attributed 4.43359375
▁the 0.37744140625
▁we 4.64453125
aker 0.0004916191101074219
- 0.97900390625
than 0.0033283233642578125
- 0.01165008544921875
expected 0.04339599609375
▁performance 2.021484375
▁to 0.207763671875
▁several 3.392578125
▁factors 0.18115234375
, 0.381103515625
▁including 0.1585693359375
▁a 1.201171875
▁missed 1.9453125
▁heart 2.064453125
▁val 0.02728271484375
ve 0.0006914138793945312
▁sale 0.07354736328125
▁to 0.291259765625
▁Iran 0.148681640625
▁due 3.291015625
▁to 0.005931854248046875
▁the 1.6044921875
▁on 3.9453125
going 0.0296173095703125
▁economic 3.208984375
▁san 0.1151123046875
ctions 0.00624847412109375
▁against 0.97900390625
▁the 0.5146484375
▁country 0.2471923828125
. 0.65625
▁The 0.9267578125
▁company 0.1884765625
▁estimated 5.203125
▁that 0.4208984375
▁the 0.438720703125
▁lost 1.4267578125
▁sale 0.439453125
▁contributed 3.80859375
▁to 0.91796875
▁a 1.072265625
▁decl 3.12109375
ine 0.0009093284606933594
▁of 0.4072265625
▁about 1.57421875
▁ 1.21484375
1 1.2060546875
▁percentage 2.22265625
▁point 0.034027099609375
▁in 0.58642578125
▁its 0.89697265625
▁re 2.328125
venue 0.0005235671997070312
▁growth 0.494140625
▁for 1.3515625
▁the 0.01114654541015625
▁quarter 0.1976318359375
. 0.08734130859375
<0x0A> 0.1376953125
In 1.251953125
▁addition 0.11822509765625
▁to 1.00390625
▁the 0.1007080078125
▁missed 1.9296875
▁sale 0.195068359375
, 0.1851806640625
▁St 0.82275390625
. 0.004886627197265625
▁J 0.0006008148193359375
ude 2.5391578674316406e-05
▁Medical 0.0498046875
▁also 0.7001953125
▁experienced 2.19140625
▁slower 3.115234375
- 1.49609375
than 0.0015506744384765625
- 0.0003540515899658203
expected 0.060272216796875
▁sales 1.419921875
▁growth 2.193359375
▁in 0.273681640625
▁its 0.7421875
▁heart 3.275390625
▁rh 0.95068359375
ythm 0.0007452964782714844
▁management 0.1937255859375
▁division 2.916015625
, 0.74169921875
▁which 0.466552734375
▁includes 2.638671875
▁pac 2.03515625
em 6.639957427978516e-05
akers 0.0146484375
▁and 0.15380859375
▁impl 2.146484375
ant 0.021881103515625
able 0.0006046295166015625
▁def 0.953125
ibr 0.0005564689636230469
ill 1.1086463928222656e-05
ators 0.005100250244140625
. 0.35107421875
▁The 0.357666015625
▁division 2.916015625
' 0.62158203125
s 3.898143768310547e-05
▁re 0.5751953125
venue 1.9431114196777344e-05
▁grew 1.400390625
▁only 1.1962890625
▁ 0.024200439453125
2 1.1396484375
% 0.1455078125
▁to 1.5869140625
▁$ 0.003612518310546875
7 1.7255859375
5 2.26953125
4 2.33203125
▁million 0.053070068359375
, 0.74609375
▁falling 2.0
▁short 0.052886962890625
▁of 9.524822235107422e-05
▁anal 0.2431640625
yst 5.245208740234375e-06
s 0.01331329345703125
' 0.0015058517456054688
▁expect 0.257080078125
ations 1.5616416931152344e-05
▁of 0.06829833984375
▁$ 0.228271484375
7 0.0221405029296875
8 2.37109375
7 2.7109375
▁million 0.076171875
. 0.0174407958984375
<0x0A> 0.06085205078125
St 2.09375
. 0.0046539306640625
▁J 0.0007719993591308594
ude 3.123283386230469e-05
▁Medical 0.00539398193359375
' 1.4404296875
s 0.00013685226440429688
▁card 2.701171875
i 0.2469482421875
ov 0.224609375
asc 0.0002474784851074219
ular 0.00015103816986083984
▁division 0.966796875
, 0.260009765625
▁which 0.033355712890625
▁includes 0.10369873046875
▁its 3.333984375
▁heart 0.72021484375
▁val 0.01157379150390625
ve 0.40771484375
▁products 0.80615234375
, 0.055389404296875
▁saw 2.62109375
▁re 1.55859375
venue 4.410743713378906e-06
▁growth 0.5751953125
▁of 0.017608642578125
▁ 0.06903076171875
7 2.119140625
% 0.024383544921875
▁to 0.01126861572265625
▁$ 0.0007390975952148438
4 1.91796875
6 2.240234375
0 2.248046875
▁million 0.00420379638671875
, 0.444091796875
▁but 2.072265625
▁still 1.6591796875
▁missed 1.1025390625
▁anal 0.04803466796875
yst 1.4901161193847656e-05
s 0.01447296142578125
' 0.0018053054809570312
▁expect 0.20068359375
ations 8.821487426757812e-06
▁of 0.05157470703125
▁$ 0.005535125732421875
4 0.048583984375
8 1.3212890625
4 2.33984375
▁million 0.0044403076171875
. 0.007625579833984375
<0x0A> 0.42041015625
The 1.4228515625
▁company 0.066650390625
' 0.75
s 9.66787338256836e-05
▁neur 4.7109375
om 0.00243377685546875
od 5.078315734863281e-05
ulation 0.0004036426544189453
▁division 0.0318603515625
, 0.033203125
▁which 0.0018739700317382812
▁includes 0.091796875
▁devices 3.1953125
▁for 0.71875
▁tre 1.115234375
ating 3.2186508178710938e-06
▁chron 0.223388671875
ic 1.33514404296875e-05
▁pain 0.00494384765625
, 0.41357421875
▁saw 0.9052734375
▁re 0.2017822265625
venue 8.344650268554688e-07
▁growth 0.1483154296875
▁of 0.0012912750244140625
▁ 0.01169586181640625
6 2.5
% 0.0131988525390625
▁to 0.001949310302734375
▁$ 0.0004513263702392578
2 0.8720703125
4 2.439453125
9 2.447265625
▁million 0.0021266937255859375
, 0.1759033203125
▁in 1.4619140625
▁line 0.00644683837890625
▁with 2.5391578674316406e-05
▁anal 0.0199127197265625
yst 1.0728836059570312e-05
s 0.00608062744140625
' 0.0009503364562988281
▁expect 0.095947265625
ations 7.033348083496094e-06
. 0.150390625
<0x0A> 0.063720703125
In 2.326171875
▁a 1.5791015625
▁statement 0.292236328125
, 0.1365966796875
▁St 0.1552734375
. 0.0017843246459960938
▁J 0.0008668899536132812
ude 2.1696090698242188e-05
▁Medical 0.0041351318359375
▁CE 0.47607421875
O 5.805492401123047e-05
▁Dan 1.263671875
▁St 0.030364990234375
arks 0.00433349609375
▁acknowled 2.7578125
ged 2.8014183044433594e-05
▁the 0.1365966796875
▁challeng 1.4697265625
es 0.071044921875
▁the 1.26171875
▁company 0.001796722412109375
▁faced 0.059722900390625
▁in 0.254638671875
▁the 0.01540374755859375
▁third 0.572265625
▁quarter 0.00013971328735351562
, 0.6728515625
▁but 0.47216796875
▁emphas 3.8046875
ized 0.000797271728515625
▁the 1.240234375
▁company 0.4521484375
' 0.0030689239501953125
s 3.62396240234375e-05
▁confidence 4.78125
▁in 0.0004646778106689453
▁its 0.0280303955078125
▁long 0.1710205078125
- 0.00012028217315673828
term 3.3736228942871094e-05
▁growth 0.23193359375
▁prospect 0.413818359375
s 9.262561798095703e-05
. 0.01166534423828125
<0x0A> 0.37939453125
" 0.07586669921875
Wh 0.8466796875
ile 2.467632293701172e-05
▁we 0.77685546875
▁are 1.6416015625
▁disappoint 0.385009765625
ed 1.7404556274414062e-05
▁with 0.5078125
▁our 0.344970703125
▁financial 3.119140625
▁results 0.320068359375
▁this 3.017578125
▁quarter 0.01131439208984375
, 0.0628662109375
▁we 0.142578125
▁remain 0.4619140625
▁confident 0.4951171875
▁in 0.023590087890625
▁our 0.41845703125
▁ability 1.533203125
▁to 0.00022709369659423828
▁execute 1.078125
▁our 1.01953125
▁strategy 1.6025390625
▁and 0.2130126953125
▁deliver 0.477294921875
▁long 0.99658203125
- 0.00135040283203125
term 0.00011813640594482422
▁growth 0.68896484375
," 0.442626953125
▁St 0.30517578125
arks 0.0006690025329589844
▁said 0.0013818740844726562
. 0.09503173828125
▁" 0.385009765625
We 0.2109375
▁continue 1.5625
▁to 0.00010561943054199219
▁make 1.365234375
▁significant 1.2275390625
▁invest 0.54248046875
ments 7.045269012451172e-05
▁in 0.0193328857421875
▁research 1.521484375
▁and 0.0036983489990234375
▁development 0.0008392333984375
, 0.8271484375
▁clin 4.57421875
ical 0.0004901885986328125
▁tri 0.9658203125
als 2.1457672119140625e-06
, 0.323486328125
▁and 0.2193603515625
▁commercial 1.58203125
ization 1.5595703125
▁efforts 1.7451171875
▁to 0.51416015625
▁drive 0.73974609375
▁innov 1.05859375
ation 0.0118255615234375
▁and 0.142578125
▁growth 1.8662109375
▁across 2.4453125
▁our 0.08917236328125
▁port 0.93896484375
folio 0.00039267539978027344
▁of 1.8642578125
▁ther 3.796875
ap 0.01335906982421875
ies 7.62939453125e-06
." 0.264892578125
<0x0A> 0.054229736328125
St 1.115234375
. 0.12939453125
▁J 0.0005741119384765625
ude 4.363059997558594e-05
▁Medical 0.00423431396484375
▁also 1.8154296875
▁announced 0.6435546875
▁several 2.564453125
▁new 0.9208984375
▁product 0.485107421875
▁launch 0.1932373046875
es 4.8041343688964844e-05
▁and 0.27099609375
▁regul 1.92578125
atory 2.1457672119140625e-06
▁appro 0.038970947265625
val 1.5497207641601562e-06
s 0.00012195110321044922
▁during 0.56494140625
▁the 0.006626129150390625
▁quarter 0.349609375
, 0.0784912109375
▁including 0.1212158203125
▁the 0.5009765625
▁US 4.2109375
▁launch 3.412109375
▁of 0.0028285980224609375
▁its 0.292724609375
▁En 2.7421875
Site 0.84228515625
▁X 4.859375
3 5.296875
▁mapping 2.060546875
▁system 0.443115234375
▁for 0.25146484375
▁card 1.0439453125
iac 0.01073455810546875
▁ab 0.62841796875
lation 0.01229095458984375
▁procedures 0.0792236328125
▁and 0.58056640625
▁the 0.1622314453125
▁European 0.74951171875
▁appro 0.6484375
val 4.76837158203125e-07
▁of 0.0205078125
▁its 0.034393310546875
▁Ass 6.21484375
urity 0.986328125
▁M 0.7568359375
RI 0.0018911361694335938
▁pac 0.8681640625
em 7.95125961303711e-05
aker 0.0307464599609375
. 0.52197265625
<0x0A> 0.29931640625
Des 1.10546875
p 6.556510925292969e-05
ite 5.7220458984375e-05
▁the 0.061492919921875
▁we 1.68359375
aker 6.556510925292969e-06
- 0.019866943359375
than 4.565715789794922e-05
- 0.0003514289855957031
expected 0.0005326271057128906
▁performance 0.392333984375
▁in 0.51171875
▁the 0.013092041015625
▁third 0.071533203125
▁quarter 5.4955482482910156e-05
, 0.0004963874816894531
▁some 6.78125
▁anal 0.01995849609375
yst 2.0265579223632812e-06
s 4.470348358154297e-05
▁remain 0.9052734375
▁optim 0.2099609375
istic 4.76837158203125e-06
▁about 0.00021398067474365234
▁St 0.2384033203125
. 0.0010166168212890625
▁J 0.0005879402160644531
ude 5.793571472167969e-05
▁Medical 0.0012989044189453125
' 0.0006952285766601562
s 6.115436553955078e-05
▁prospect 1.3671875
s 1.4662742614746094e-05
. 0.9296875
▁In 0.740234375
▁a 0.0277099609375
▁research 0.783203125
▁note 0.0118255615234375
, 0.28515625
▁J 2.578125
ef 0.56201171875
fer 2.2172927856445312e-05
ies 0.0015077590942382812
▁& 5.83984375
▁Co 0.1654052734375
▁anal 0.73291015625
yst 2.3365020751953125e-05
▁Raj 1.5185546875
▁Den 0.095947265625
ho 0.04705810546875
y 0.0093536376953125
▁noted 1.62890625
▁that 0.03594970703125
▁the 0.0633544921875
▁company 0.0100250244140625
' 0.14404296875
s 2.4080276489257812e-05
▁card 3.255859375
i 0.2352294921875
ov 0.08563232421875
asc 0.0002225637435913086
ular 1.3709068298339844e-05
▁division 0.283203125
▁" 3.650390625
cont 1.2392578125
in 0.0020885467529296875
ues 0.1328125
▁to 0.0095062255859375
▁perform 2.828125
▁well 0.2418212890625
," 1.4794921875
▁and 0.61181640625
▁that 0.2298583984375
▁the 0.70068359375
▁company 0.82861328125
' 0.077392578125
s 9.179115295410156e-06
▁recent 2.91015625
▁product 1.0693359375
▁launch 0.0293731689453125
es 0.00012409687042236328
▁" 2.29296875
should 1.1162109375
▁help 1.3720703125
▁support 4.0859375
▁growth 1.14453125
▁in 0.6748046875
▁the 0.300048828125
▁coming 1.2578125
▁year 5.29296875
." 0.0189361572265625
<0x0A> 0.11370849609375
Sh 6.45703125
ares 0.023193359375
▁of 0.01198577880859375
▁St 0.00983428955078125
. 0.00220489501953125
▁J 0.0009369850158691406
ude 1.4066696166992188e-05
▁Medical 0.0005173683166503906
▁were 0.6640625
▁down 0.302734375
▁ 1.087890625
2 1.3896484375
. 0.48779296875
2 2.203125
% 0.0850830078125
▁in 0.160400390625
▁pre 1.208984375
market 0.5107421875
▁trad 0.01355743408203125
ing 1.8715858459472656e-05
▁on 0.476318359375
▁T 0.0268402099609375
ues 1.9669532775878906e-05
day 1.0013580322265625e-05
▁following 2.666015625
▁the 0.003490447998046875
▁release 1.072265625
▁of 8.428096771240234e-05
▁the 0.10736083984375
▁third 2.658203125
- 0.017333984375
qu 6.103515625e-05
arter 1.1086463928222656e-05
▁ear 0.77880859375
nings 0.00013387203216552734
▁report 0.054656982421875
. 0.01503753662109375
▁The 2.080078125
▁company 0.73974609375
' 0.302001953125
s 8.749961853027344e-05
▁stock 0.2225341796875
▁has 0.424072265625
▁fallen 1.916015625
▁about 1.5048828125
▁ 0.00011682510375976562
1 0.91357421875
0 1.43359375
% 0.00304412841796875
▁since 0.580078125
▁the 0.07623291015625
▁beginning 0.466552734375
▁of 0.00011157989501953125
▁the 0.053955078125
▁year 0.0017328262329101562
. 0.75439453125
